240 related articles for article (PubMed ID: 20124220)
1. Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.
Gutierrez A; Sanda T; Ma W; Zhang J; Grebliunaite R; Dahlberg S; Neuberg D; Protopopov A; Winter SS; Larson RS; Borowitz MJ; Silverman LB; Chin L; Hunger SP; Jamieson C; Sallan SE; Look AT
Blood; 2010 Apr; 115(14):2845-51. PubMed ID: 20124220
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in
Carr T; McGregor S; Dias S; Verykokakis M; Le Beau MM; Xue HH; Sigvardsson M; Bartom ET; Kee BL
Front Immunol; 2022; 13():845488. PubMed ID: 35371057
[TBL] [Abstract][Full Text] [Related]
3. Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia.
Guo X; Zhang R; Liu J; Li M; Song C; Dovat S; Li J; Ge Z
PLoS One; 2015; 10(5):e0125429. PubMed ID: 25942645
[TBL] [Abstract][Full Text] [Related]
4. The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Larson Gedman A; Chen Q; Kugel Desmoulin S; Ge Y; LaFiura K; Haska CL; Cherian C; Devidas M; Linda SB; Taub JW; Matherly LH
Leukemia; 2009 Aug; 23(8):1417-25. PubMed ID: 19340001
[TBL] [Abstract][Full Text] [Related]
5. Repressed BMP signaling reactivates NKL homeobox gene MSX1 in a T-ALL subset.
Nagel S; Ehrentraut S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Leuk Lymphoma; 2015 Feb; 56(2):480-91. PubMed ID: 24844359
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biological relevance of genetic alterations in pediatric T-cell acute lymphoblastic leukemia in Taiwan.
Yeh TC; Liang DC; Liu HC; Jaing TH; Chen SH; Hou JY; Yang CP; Huang YJ; Yao HW; Huang TY; Lin TH; Shih LY
Pediatr Blood Cancer; 2019 Jan; 66(1):e27496. PubMed ID: 30280491
[TBL] [Abstract][Full Text] [Related]
7. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.
Gutierrez A; Kentsis A; Sanda T; Holmfeldt L; Chen SC; Zhang J; Protopopov A; Chin L; Dahlberg SE; Neuberg DS; Silverman LB; Winter SS; Hunger SP; Sallan SE; Zha S; Alt FW; Downing JR; Mullighan CG; Look AT
Blood; 2011 Oct; 118(15):4169-73. PubMed ID: 21878675
[TBL] [Abstract][Full Text] [Related]
8.
Sırma Ekmekci S; Emrence Z; Abacı N; Sarıman M; Salman B; Ekmekci CG; Güleç Ç
Turk J Haematol; 2020 Nov; 37(4):226-233. PubMed ID: 32586085
[TBL] [Abstract][Full Text] [Related]
9. High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response.
Remke M; Pfister S; Kox C; Toedt G; Becker N; Benner A; Werft W; Breit S; Liu S; Engel F; Wittmann A; Zimmermann M; Stanulla M; Schrappe M; Ludwig WD; Bartram CR; Radlwimmer B; Muckenthaler MU; Lichter P; Kulozik AE
Blood; 2009 Jul; 114(5):1053-62. PubMed ID: 19406988
[TBL] [Abstract][Full Text] [Related]
10. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
Ferrando AA; Neuberg DS; Staunton J; Loh ML; Huard C; Raimondi SC; Behm FG; Pui CH; Downing JR; Gilliland DG; Lander ES; Golub TR; Look AT
Cancer Cell; 2002 Feb; 1(1):75-87. PubMed ID: 12086890
[TBL] [Abstract][Full Text] [Related]
11. The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy.
Yu S; Zhou X; Steinke FC; Liu C; Chen SC; Zagorodna O; Jing X; Yokota Y; Meyerholz DK; Mullighan CG; Knudson CM; Zhao DM; Xue HH
Immunity; 2012 Nov; 37(5):813-26. PubMed ID: 23103132
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia.
Kühnl A; Gökbuget N; Kaiser M; Schlee C; Stroux A; Burmeister T; Mochmann LH; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Blood; 2011 Dec; 118(24):6362-7. PubMed ID: 22010100
[TBL] [Abstract][Full Text] [Related]
13. Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; MacLeod RA
Leuk Res; 2010 Apr; 34(4):521-8. PubMed ID: 19608273
[TBL] [Abstract][Full Text] [Related]
14. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia.
Yang L; Chen F; Zhu H; Chen Y; Dong B; Shi M; Wang W; Jiang Q; Zhang L; Huang X; Zhang MQ; Wu H
Nat Commun; 2021 Jun; 12(1):3708. PubMed ID: 34140506
[TBL] [Abstract][Full Text] [Related]
15. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
[TBL] [Abstract][Full Text] [Related]
16. Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia.
Erbilgin Y; Hatirnaz Ng O; Can I; Firtina S; Kucukcankurt F; Karaman S; Karakas Z; Celkan TT; Zengin E; Aylan Gelen S; Nihal Ozdemir G; Yildirmak Y; Dogru O; Tansel T; Khodzhaev K; Toluk O; Ozbek U; Sayitoglu M
Int J Lab Hematol; 2021 Oct; 43(5):1093-1103. PubMed ID: 33844466
[TBL] [Abstract][Full Text] [Related]
17. Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia.
La Starza R; Barba G; Demeyer S; Pierini V; Di Giacomo D; Gianfelici V; Schwab C; Matteucci C; Vicente C; Cools J; Messina M; Crescenzi B; Chiaretti S; Foà R; Basso G; Harrison CJ; Mecucci C
Haematologica; 2016 Aug; 101(8):951-8. PubMed ID: 27151989
[TBL] [Abstract][Full Text] [Related]
18. Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia.
Bonnet M; Loosveld M; Montpellier B; Navarro JM; Quilichini B; Picard C; Di Cristofaro J; Bagnis C; Fossat C; Hernandez L; Mamessier E; Roulland S; Morgado E; Formisano-Tréziny C; Dik WA; Langerak AW; Prebet T; Vey N; Michel G; Gabert J; Soulier J; Macintyre EA; Asnafi V; Payet-Bornet D; Nadel B
Blood; 2011 Jun; 117(24):6650-9. PubMed ID: 21527520
[TBL] [Abstract][Full Text] [Related]
19. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
[TBL] [Abstract][Full Text] [Related]
20. Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors.
Silva A; Jotta PY; Silveira AB; Ribeiro D; Brandalise SR; Yunes JA; Barata JT
Haematologica; 2010 Apr; 95(4):674-8. PubMed ID: 20015880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
